Cybercriminals are weaponizing the same tools that healthcare providers use to operate and maintain secure IT systems, HHS warned in a recent report. Providers can protect themselves by having a firm grasp of what their IT environment looks like, as this may help them spot any suspicious security tool commands.
By Frank Vinluan Wednesday, October 12, 2022 7:00 AM
Ascidian Therapeutics is developing therapies for inherited disorders that work by editing RNA with an approach that could offer advantages over currently available genetic medicines. The biotech's lead program is in preclinical development for Stargardt disease, a rare eye disorder caused by multiple genetic mutations.
Rethinking the entire patient-as-consumer experience to create something that's pure, clean, modern and friendly is a fundamental requirement for building and maintaining their brand.
By Marissa Plescia Tuesday, October 11, 2022 6:14 PM
Almost 40% of employers made changes to their retiree healthcare benefits in the last three years, while another 63% plan to in the next three three years, the Willis Towers Watson survey found. Some are looking to replace their traditional group plan offerings with individual insurance through a private marketplace.
By Christina Andrews Tuesday, October 11, 2022 4:28 PM
How do organizations optimize and scale business intelligence? Here are five basic steps to consider when developing dashboards to assess your operational, financial and quality components within the care at home industry.
By Marissa Plescia Tuesday, October 11, 2022 3:32 PM
It is Mark Cuban Cost Plus Drug Company's first collaboration with a health plan. The pharmacy company will not be replacing Capital Blue Cross' existing pharmacy benefits manger, but instead will be an additional option for members to choose.
By Stephanie Baum Tuesday, October 11, 2022 1:45 PM
A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.
The Act, along with mandating the adoption of electronic prior authorization, requires greater levels of transparency, approval rates, and rationale for denied requests.
By Frank Vinluan Tuesday, October 11, 2022 1:06 PM
Dice Therapeutics reported the first human data for its oral psoriasis drug designed to hit the same pro-inflammatory protein blocked by blockbuster antibody drugs from Novartis and Eli Lilly. The potential for Dice's pill to offer a competitive oral alternative pushed the biotech's stock skyward by nearly 80%.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments